Drug intelligence / Profile preview

xiao'er baishou wan

Development stage: Unknown
Lead developer: Liaoning Jindan Pharmaceutical
Administration: Oral

Overview

Xiao'er Baishou Wan is an approved traditional Chinese medicine (TCM) product manufactured by Liaoning Jindan Pharmaceutical. It is specifically formulated for pediatric patients to address digestive disorders stemming from spleen and stomach weakness. The preparation typically consists of a complex blend of herbal ingredients such as Codonopsis, Atractylodes, and Hawthorn, which work synergistically to enhance gastrointestinal motility, stimulate digestive enzyme secretion, and alleviate symptoms like poor appetite, abdominal bloating, and infantile malnutrition (ganji). It is marketed in China as a regulated pharmaceutical product for the treatment of functional dyspepsia and related pediatric conditions.

Brand names: 小儿百寿丸
Other names: Xiao'er Baishou WanXiaoer Baishou Wan

Beyond the preview

Go deeper on xiao'er baishou wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiao'er baishou wan.

Explore the full profile